Tao Liu

6PUBLICATIONS
17CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersNanoscale characterisation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 25, 2026
Targeting ADAR1 lactylation activates innate immune and overcomes chemoresistance in ovarian cancer.

|Mar 10, 2026
Alternative polyadenylation links RNA processing to iron metabolism in human erythropoiesis.

Shan Yu, Xianyan Zeng, Jing Chen

|Dec 01, 2025
ALYREF condensation stabilizes m5C-modified PARP10 mRNA and promotes PI3K-AKT signaling in ovarian cancer.

Hongyan Zhao, Qinglv Wei, Zhi Luo

|Aug 07, 2025
SRSF9 Forms Phase-Separated Condensates to Promote Ovarian Cancer Progression by Inducing RNA Alternative Splicing That Is Inhibited by m6A Modification.

Xinzhao Zuo, Jie Xu, Dan Yang

|Feb 25, 2025
Genome-wide profiling of N6-methyladenosine-modified pseudogene-derived long noncoding RNAs reveals the tumour-promoting and innate immune-restraining function of RPS15AP12 in ovarian cancer.

Jie Xu, Yifei Ren, Jiayi Lu

|Oct 10, 2024
m6A-driven NAT10 translation facilitates fatty acid metabolic rewiring to suppress ferroptosis and promote ovarian tumorigenesis through enhancing ACOT7 mRNA acetylation.

Yujiao Liu, Jia Li, Jie Xu

Pageof 1

Frequent Collaborators

5 joint publications

Ping Yi

2 joint publications

Wei Wang

2 joint publications

Qinglv Wei

1 joint publications

Yong Zhu